PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.77%
Negative revenue growth while NXPI stands at 31.47%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.59%
Negative gross profit growth while NXPI is at 21.63%. Joel Greenblatt would examine cost competitiveness or demand decline.
-25.49%
Negative EBIT growth while NXPI is at 116.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.18%
Negative operating income growth while NXPI is at 116.00%. Joel Greenblatt would press for urgent turnaround measures.
-29.30%
Negative net income growth while NXPI stands at 258.47%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-29.11%
Negative EPS growth while NXPI is at 259.57%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.57%
Negative diluted EPS growth while NXPI is at 255.32%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.43%
Share reduction while NXPI is at 0.34%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.42%
Diluted share reduction more than 1.5x NXPI's 2.82%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.43%
Dividend growth of 0.43% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-58.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-65.34%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
103.42%
10Y revenue/share CAGR above 1.5x NXPI's 32.50%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
38.18%
5Y revenue/share CAGR 1.25-1.5x NXPI's 32.50%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
17.88%
3Y revenue/share CAGR at 50-75% of NXPI's 32.50%. Martin Whitman would question if the firm lags behind competitor innovations.
557.38%
10Y OCF/share CAGR above 1.5x NXPI's 103.04%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
25.82%
Below 50% of NXPI's 103.04%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-8.46%
Negative 3Y OCF/share CAGR while NXPI stands at 103.04%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
339.00%
Net income/share CAGR above 1.5x NXPI's 127.76% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
54.62%
Below 50% of NXPI's 127.76%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
14.40%
Below 50% of NXPI's 127.76%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
23.29%
Equity/share CAGR of 23.29% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
27.79%
Equity/share CAGR of 27.79% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
21.98%
Equity/share CAGR of 21.98% while NXPI is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
526.91%
Dividend/share CAGR of 526.91% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
332.92%
Dividend/share CAGR of 332.92% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
30.81%
3Y dividend/share CAGR of 30.81% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.29%
AR growth well above NXPI's 5.71%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.39%
Inventory growth well above NXPI's 4.68%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.68%
Negative asset growth while NXPI invests at 1.52%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.75%
Under 50% of NXPI's 12.58%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
7.65%
R&D dropping or stable vs. NXPI's 20.31%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.54%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.